Jacobs Levy Equity Management
ENZN

Jacobs Levy Equity Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Jacobs Levy Equity Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-523,865
Closed -$246K – 1314
2016
Q1 		$246K Buy
523,865
+50,157
+11% +$24.5K 0.01% 927
2015
Q4 		$323K Buy
473,708
+116,068
+32% +$92K 0.01% 641
2015
Q3 		$347K Buy
357,640
+95,500
+36% +$118K 0.01% 632
2015
Q2 		$315K Sell
262,140
-51,717
-16% -$65.9K 0.01% 647
2015
Q1 		$333K Buy
313,857
+21,100
+7% +$21.8K 0.01% 637
2014
Q4 		$319K Buy
292,757
+56,200
+24% +$59K 0.01% 675
2014
Q3 		$255K Buy
+236,557
New +$292K ﹤0.01% 712
2014
Q2 		– Sell
-198,536
Closed -$204K – 1005
2014
Q1 		$204K Sell
198,536
-23,088
-10% -$23.8K ﹤0.01% 820
2013
Q4 		$257K Buy
221,624
+36,736
+20% +$56.6K ﹤0.01% 835
2013
Q3 		$311K Buy
184,888
+92,774
+101% +$172K 0.01% 787
2013
Q2 		$184K Buy
+92,114
New +$270K ﹤0.01% 899

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Jacobs Levy Equity Management's ENZN Position: Q2 2016 in Review

Jacobs Levy Equity Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 523,865 shares — an estimated $246K sold.

Jacobs Levy Equity Management first reported a position in ENZN in Q2 2013 and held it in 11 quarters. The position peaked at $347K in Q3 2015. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Jacobs Levy Equity Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 523,865 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $246K.
  • Jacobs Levy Equity Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 11 quarters.
  • Jacobs Levy Equity Management's ENZON PHARMACEUTICALS INC position peaked at $347K in Q3 2015.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.